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Migration capacity is an important feature of tumor cells. There are several approaches to 
analyze the dynamics of cancer cell migration in vitro. The model of initiation of cell migration 
from 3D multicellular spheroids onto growth surface is one of the closest to the in vivo condi-
tions. Aim. Optimization of the model to study tumor cell mobility for several days. Methods. 2D 
and 3D MCF-7 cell culture, immunofluorescence analysis and image analysis using the Fiji 
computer software. Results. Unification of spheroid size allowed avoiding a significant data 
deviation. The obtained spheroids spread completely for three days. The highest migration 
ratio was observed on the second day. The proliferation level was similar during each day of 
the  three-day experiment; it did not exceed 3 %. The validity of the model was tested after 
migration inhibition by a mTOR signaling inhibitor rapamycin. Additionally, this model was 
successfully applied to immunofluorescence study of p85S6K1 subcellular localization in 
moving MCF-7 cells. Conclusions. Double filtration of multicellular spheroids allowed uni-
fication of their size; this promotes an adequate interpretation of the migration assay. This 
model allows to study tumor cell migration dynamics and can be further used for development 
of anticancer drugs.
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Introduction
The ability of malignant tumors to form metas-
tases is a critical step of the cancer progression 
and distinguishes malignant tumor cells from 
benign or normal ones [1].This feature of tumor 
cells is determined by their ability to migrate 
and penetrate surrounding tissues. Often the 
metastases but not primary tumors lead to the 
death of organism. That is why the processes 
of cancer cell migration and invasion are the 
most important targets of the anti-cancer basic 
Methods ISSN 1993-6842 (on-line); ISSN 0233-7657 (print) 
Biopolymers and Cell. 2018. Vol. 34. N 6. P 477–486 
doi: http://dx.doi.org/10.7124/bc.000992
478
A. O. Kravchenko, V. R. Kosach, K. A. Shkarina et al.
research and drug development. In normal adult 
mammalian organism, only immune and pla-
centa cells are able to invade corresponding 
tissues. However, an ability to migrate is not 
limited to these cell types. There are also many 
other cell populations that migrate to their final 
niche in the course of embryogenesis and post-
embryonic development, including the develop-
ment of cardiovascular system, central nervous 
system, and many others [2–6].
Nowadays, there are several approaches to 
evaluate the cell migration and locomotor 
properties in vitro. The most widely employed 
methods are the transwell migration and inva-
sion assay, the “wound healing” assay and the 
initiation of cell migration from multicellular 
spheroids or tissue explants into matrigel or 
onto growth surface. Each of them has the 
advantages and disadvantages which leads to 
the need of their improvement.
The first mentioned method is the transwell 
migration and invasion assays. The basis of 
this method is the initiation of directed cell 
movement through the pores of the transwell 
membrane toward the chemoattractant. This 
approach is widely used in cancer research and 
especially for test of antitumor properties of 
corresponding drugs or their combination [1]. 
However, this approach has several disadvan-
tages, in particular time restrictions, which 
limits the duration of the study to 24–48 hours; 
relatively high costs, and the need of selecting 
the optimal conditions for each particular cell 
type and the type of attractant used. Another 
widely applied method is the wound healing 
assay. This method is based on estimation of 
closure dynamics of the artificially formed free 
space in the confluent cell monolayer. Alike 
previous case, the main disadvantage of this 
method is limitation of experiment duration, 
usually up to 24 hours to exclude the effect of 
cell proliferation in freed space. The third 
experimental strategy of migration estimation 
is based on the transformation of 3D multicel-
lular spheroid into 2D cellular monolayer 
colony. This method provides several advan-
tages over above-mentioned approaches; the 
main of them is that 3D culture of cancer cells 
more closely reflects in vivo conditions [7]. 
Besides, it also enables easy detection of many 
of biochemical and morphological properties 
of moving cells. Depending on the studied cell 
type, this model provides an opportunity to 
characterize either collective or single-cell 
migration. However, there are also several 
known limitations to this model application. 
The major difficulty is significant variation of 
spheroid sizes. It, in turn, complicates the 
comparison of cell migration kinetics between 
spheroids with initially different size. 
Therefore, there is a strong need for further 
unification of the multicellular spheroid size. 
There are several approaches to obtain the 
spheroids of similar sizes including handling 
drop method or application of special multi-
well plates, etc., but they require preliminary 
preparation and are relatively expensive. From 
our point of view the double filtration of spher-
oid suspension through nylon mesh filters 
could provide strong unification of spheroid 
size.
Another issue which should be regarded is 
the input of proliferation in the value of dis-
tance or surfaces covered by the cells in migra-
tion tests. To compare the dynamics of cell 
migration at regular terms, it is necessary to 
ensure that the level of proliferation for the 
same time period was also similar.
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To test the proposed approach, the inhibi-
tion of cell locomotion was applied. 
The cell migration is strongly affected by a 
variety of growth factors, hormones, cytokines 
and other chemical cues, which induce the 
activation of several signaling pathways with-
in migrating cell. The PI3K/mTOR/S6K cas-
cade has been previously described as an im-
portant regulator of mammalian cell migration 
[8]. In normal tissue this pathway is involved 
in the control of many intracellular events, 
including protein synthesis regulation, the 
G1/S phase cell cycle transition and many oth-
ers [9, 10]. mTOR/S6K signaling over activa-
tion and over expression has been observed in 
many diseases including cancer, diabetes, and 
other [11–13]. There are some significant dif-
ferences in PI3K/mTOR/S6K signaling in 3D 
vs. a 2D cell culture system [14]. Earlier, we 
confirmed that rapamycin, an inhibitor of 
mTOR signaling, decreased the MCF-7 cell 
locomotion in scratch test. So, it was used in 
this study for validation of optimized locomo-
tion assay [15].
Additionally, the model of outspreading 
spheroids can be applied for immunochemical 
assay. Earlier we revealed the subcellular re-
localization of p70S6K1 from the cytoplasm 
into the nuclei of MCF-7 cells in course of 
migration from spheroid onto growth surface 
by immunofluorescent analysis [16]. One of 
the explanations of the kinase relocalization 
was its association with the transcription factor 
TBR2, expressed in actively migrating cells 
like embryonic, cancer cells and lymphocytes. 
Kinase of ribosomal protein S6 (S6K1) is one 
of the key links of the mTOR signaling path-
way. S6K1 has several known isoforms: 
p85(S6K1), the most highly expressed isoform 
p70(S6K1), and additionally less studied iso-
forms p60(S6K1) and p31(S6K1). Both 
p85(S6K1) and p70(S6K1) isoforms have been 
previously shown to be regulated through 
phosphorylation by the mTOR/S6K, PI3K/Akt 
signaling pathway [9]. Initially p85S6K1 was 
regarded as a nuclear isoform of S6K1, more-
over it contained the signal of nuclear localiza-
tion at N-terminus of molecule. But later it was 
observed in cytoplasm as well. p70S6K1 and 
p85S6K1 have both common and different 
effectors and targets. To compare their subcel-
lular distribution in migrating cells, immuno-
fluorescent revealing of p85S6K1 in outspread-
ing spheroids of MCF-7 cells was performed.
So, the aim of this study was to improve the 
method of initiation of cell migration from the 
3D multicellular spheroids cells onto the 
growth surface. Namely, the MCF-7 cell spher-
oid size unification was performed by double 
filtration through nylon mesh filters with pore 
diameter 30 and 100 mm; the index of MCF-7 
cell proliferation at the 1st, 2nd, and 3rd days 
in outspreaded spheroids was estimated; the 
validity of quantitative migration assay was 
tested using migration inhibition; availability 
of the model for immunofluorescent analysis 
was confirmed by corresponding assay of the 
p85S6K1 relocalization in course of cell mi-
gration.The proposed approach could be useful 
for basic cancer research and anticancer drug 
development, as well as for other assay of the 
cell locomotion dynamics.
Materials and Methods
Cell culture.MCF-7 cell line derived from 
metastatic site of malignant breast tumor was 
used in this study [17]. MCF-7 cells were 
cultured in Dulbecco’s Modified Eagle’s me-
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dium (DMEM) (Sigma, USA) supplemented 
with 10 % fetal bovine serum (FBS, CellSera, 
Australia), 4 mM glutamine (Sigma, USA), 
50 U / ml penicillin and 50 g / ml streptomycin 
(Sigma, USA) at 37 ° C in a 5 % CO2 hu-
midified incubator. 
Generation of spheroids. For multicellular 
spheroids generation, confluent monolayer of 
MCF-7 cells was detached with 0.25 % tryp-
sin, 0.02 % EDTA in Hank′s Balanced Salt 
Solution (Sigma, USA) to generate single cell 
suspension, which was transferred into the 
10-centimeter Petri dishes coated with 1 % 
agarose (Serva, Heidelberg, Germany). Cells 
were further cultivated for three days. The 
resulting suspension of spheroids of different 
size was subjected to the two-step filtration. 
First, spheroids were passed through a sterile 
nylon mesh (Spectrum, USA) with a pore di-
ameter of 100 μm to remove large cell aggre-
gates. The second step of the filtration was 
carried using sterile filter mesh (Spectrum, 
USA) with a pore diameter of 30μm for single 
cell elimination.
The transformation of spheroids in a mono-
layer cell colony. The obtained spheroids of 
uniform size were transferred into the 6-well 
plates with a fresh complete medium. The 
migration and proliferation processes were 
analyzed at 0, 24, 48 and 72 hours post filtra-
tion. The images were acquired using bright 
field and phase contrast microscopy (CETI 
Versus inverted microscope, CETI, Belgium, 
and Leica DM 1000, Leica Microsystems, 
Germany, Magnification 25x, 100x). Only the 
colonies of round shape were selected for fur-
ther analysis. A colony area was determined 
using Fiji software, and an approximate colo-
ny radius was calculated using formula: 
r=√S/π. The migration activity was expressed 
as a difference of colonies radii at correspond-
ing time points. To alter the cell migration 
dynamics the treatment of MCF-7 multicel-
lular spheroids with 10 nM rapamycin 
(Calbiochem biochemicals, Los Angeles, USA) 
was applied and then the cell locomotion was 
estimated.  
Proliferation activity analysis. The number 
of mitotic cells was calculated at 24, 48 and 
72 hours of spheroid outspreading. The im-
ages of spheroids were taken at indicated time 
points, and then the number of proliferating 
cells of corresponding morphology was calcu-
lated. Besides, cultured on cover glasses colo-
nies were fixed with 10 % formaldehyde solu-
tion (Thermo Scientific, USA) for 15 minutes 
and afterwards stained with 2 % Hoechst 
33342 (Molecular Probes, USA) in the dark 
for 25 minutes. Samples were mounted on 
slides into Mowiol mounting medium (Sigma-
Aldrich, St. Louis, USA) containing 2.5 % 
DABCO (Sigma-Aldrich, St. Louis, USA), and 
amount of mitotic cells were calculated using 
fluorescent microscopy by morphological fea-
tures. Index of proliferation was calculated as 
the per cent of mitotic cells in the population 
of spreading spheroid.
Immunofluorescence analysis. Cultured on 
cover glasses colonies at 0, 24, 48 and 72 hours 
were fixed with 10 % formaldehyde solution 
for 15 minutes, as described previously. For 
membrane permeabilization, the cells were 
treated with a 0.2 % Triton X-100 in PBS solu-
tion and afterwards incubated for 30 min at 
room temperature in 10 mM cupric sulphate 
and 50 mM ammonium acetate (pH 5.0) to 
reduce autofluorescence. Non-specific antibody 
binding was blocked with 10 % FCS in PBS for 
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30 min at 37 °C. Anti-p85(S6K1) rabbit poly-
clonal antibodies were applied in dilution 1:100 
overnight at 4 °C [18]. Secondary FITC conju-
gated anti-rabbit antibodies (Jackson Immuno 
Research Laboratories, Pennsylvania, USA) 
were applied in dilution 1:400 for 1h at 37 °C 
in humidified chamber. Samples were mounted 
into the Mowiol medium (Sigma-Aldrich, St. 
Louis, USA) containing 2.5 % DABCO (Sigma-
Aldrich, St. Louis, USA). Fluorescent micros-
copy was performed using Leica DM 1000 
fluorescent microscope (Leica Micro systems, 
Wetzlar, Germany, Canon PowerShots70, 
Magnification 100x, 400x).
Statistical analysis. All image analysis was 
performed using the Fiji software [19]. Data 
analysis was performed using Origin 9. All 
data are  expressed as median +/- SD. Each 
experiment was repeated at least three times. 
Results and Discussion
Unification of spheroid size. One of the main 
drawbacks of the spheroid to monolayer tran-
sition model is the significant size variation of 
multicellular spheroids generated by the stan-
dard liquid overlay method (Fig. 1a). To over-
come this obstacle, an additional step of dou-
ble filtration of generated spheroids suspension 
was applied. It enabled to unify the size of the 
colonies used for subsequent analysis, and, so, 
to perform proliferation and migration mea-
surements more accurately and rapidly 
(Fig. 1b). 
At the first step of method optimization the 
filtration of spheroid suspension through the 
nylon mesh with a pore diameter of 100 μm 
was applied to eliminate large cell clusters in 
the resulting culture. Subsequent purification 
from small cell aggregates and single cells was 
performed using a 30-μm pore diameter nylon 
mesh. For further analysis of purified colonies, 
the value of median of spheroid size was de-
termined using image analysis. Average of 
diameter median of MCF-7 cells spheroids in 
5 experiments was 47.65 μm with standard 
deviation ±21.79μm. It confirmed that filtration 
A
 
B
Fig. 1. A — Suspension of  MCF-7 multicellular spheroids before filtration. Black arrows and circles indicate spher-
oids of different size. Oc.10x, ob. 10x. B — Suspension of  MCF-7 multicellular spheroids after double filtration. Blue 
arrows indicate spheroids of similar size. Oc.10x, ob. 2,5x.
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was successful and the population of spheroids 
of uniform size was generated.
Determination of proliferation activity. 
Another major technical issue in multi-day 
migration assays is the proliferation of studied 
cells. Since proliferation has been shown to 
affect other migration assays, it was important 
to compare the proliferation activity of cells 
in our model on the 1st, 2nd and 3rd days of 
spheroid spreading. To analyze this parameter 
in the proposed system, the cell proliferation 
index after consecutive time periods was esti-
mated .We used two different approaches. In 
the first case, the number of mitotic cells was 
calculated directly in course of spheroid 
spreading using transmitted light microscopy. 
The mitotic cells in monolayer condition ac-
quire morphology distinct from the interphase 
cells. Such cells become round, they exhibit 
condensed chromatin, the morphology of 
which reflects the corresponding stage of mi-
tosis (Fig 2). The per cent of such cells was 
determined in each outspreading spheroid. 
In the second case, the number of prolifer-
ating cells was detected at mentioned time 
points using Hoechst 33342 staining and fluo-
rescent microscopy (Fig.3). 
The proliferation index was expressed as the 
percentage of dividing cells in each colony 
analyzed. We detected that the level of cell 
proliferation after 24, 48, and 72 hours of migra-
tion assay did not exceed 3 %. In particular, we 
obtained the values for 24 hours of 2.54 %, for 
48 — 2.6 %, for 72 — 2.94 %. This indicates 
a similar effect of proliferative activity on the 
spreading dynamics of the MCF-7 spheroids at 
every time point, allowing us to neglect a po-
tential proliferation influence at comparison of 
migration dynamics at neighboring time points.
Migration assay. In order to determine the 
distance that cells passed during migration 
process, the radii of outspreading spheroids 
were measured after 0, 24, 48, and 72 h of 
cultivation. The difference between the radii 
values at neighboring time points was further 
regarded as the length of the cell migration 
track. From our point of view, the comparison 
of linear parameters in migration assay is more 
adequate than of squares since it is more valid 
characteristic of the directed movement.
For this aim, the area of each spheroid was 
quantified using Fiji software at all abovemen-
tioned time points, and radius was calculated 
as described in Materials and Methods section. 
We observed that a migration rate reached the 
maximum at 48 hours post-filtration and de-
creased after 72 hours, which morphologi-
cally corresponded to the complete spreading 
Fig. 2. Determination of mitotic cells in outspreading 
MCF-7 cell spheroids at the 2nd day of migration initia-
tion. Arrows point out metaphase plates. Transmitted 
light microscopy. Oc.10., ob.20x. 
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of spheroids (Fig. 4, Fig. 5). Thus, the median 
of migration distance after 24 hours was 
7.64 mm, after 48 hours the cells passed an-
other 8.24 mm and after 72 hours another 
6.8 mm.
For further validation of the proposed mod-
el, the analysis of locomotor properties of 
MCF-7 cells under effect of Rapamycin 
(mTOR inhibitor) was applied. Rapamycin and 
its derivatives are the most well-known in-
hibitors of mTOR and are currently undergoing 
clinical trials as novel anticancer agents. These 
compounds have been shown to inhibit the 
activity of mTOR complexes and significantly 
decrease tumor cell motility in vitro [20]. 
Therefore, we analyzed whether rapamycin 
would affect the MCF-7 cell migration from 
spheroids onto the growth surface. Noteworthy, 
the effect of rapamycin on the rate of cell mi-
gration during the first day was minimal and 
cells overcame 8.13 mm, whereas on the sec-
ond and third days of the experiment, a sig-
nificant decrease in the cell migration rate was 
observed, 3.65 mm and 1.94 mm respectively 
(Fig. 4). It could be potentially attributed to 
the inhibition of mTORC2 complex involved 
in the cytoskeleton regulation [19]. So, this 
result confirmed the suitability of the proposed 
model for the assessment of cell migration and 
its inhibition. 
Immunofluorescence analysis
The presented model allowed applying an im-
munofluorescence analysis of intracellular lo-
calization of variety antigens in the migrating 
A
 
B
 
C
Fig. 4. Cultured multicellular spheroids of  MCF-7 cells after 24 (a), 48 (b) and 72 (c) hours of spreading. Transmitted 
microscopy. Oc.10x, ob.2,5x.
Fig. 3. Detection of mitotic cells in MCF-7 outspreaded 
spheroid at the 2nd day of experiment. DNA counter-
stained with Hoechst 33342. Arrows point out proliferat-
ing cells. Oc.10x, ob.10x.
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cells of outspreading spheroids. Earlier we 
revealed the subcellular relocalization of S6K1 
from the cytoplasm into the nuclei of MCF-7 
cells after initiation of migration [16]. The 
presented model was used to determine the 
distribution of one of S6K1 isoforms namely 
p85S6K1 in the migrating MCF-7 cells. In 3D 
conditions MCF-7 cells demonstrated pre-
dominantly cytoplasm localization of p85S6K1 
(Fig. 6a, white arrows). After initiation of cell 
migration a bright positive reaction in the nu-
clei (primarily on the leading edge) appeared 
for p85S6K1 (Fig. 6a, green arrows). Note-
worthy, in 2D monolayer conditions the nuclei 
of MCF-7 cells were strongly positive for 
p85S6K1 (Fig. 6b). The obtained results could 
suggest the important role of p85S6K1 real-
izing in the nuclei for cell spreading and mi-
gration. Besides, the applied model allowed 
registration of the change of subcellular dis-
tribution of the intracellular protein in migra-
ting cell. 
Proposed optimisation of cell migration 
model namely spheroid size unification and 
estimation of proliferation activity allow to 
apply this model for detection of locomotor 
properties of  the breast cancer MCF-7 cells 
during 3 days. Besides, the model is useful 
for investigation of the subcellular localiza-
tion of proteins involved in the regulation of 
cell locomotion. This approach will be help-
ful for anticancer drug test as well as for 
study of the basic mechanisms of tumor pro-
gression.
Fig. 5. Dynamics of MCF-7 cell mi-
gration from 3D spheroid onto the 
growth surface at 0, 24, 48, 72 hours 
post-filtration in standard cell culture 
conditions (blue line) or under the 
Rapamycin treatment (10 nM) 
(red line).
A
 
B
Fig. 6. Immunofluorescence detec-
tion of p85S6K1subcellular distribu-
tion in MCF-7 cell outspreading 
spheroid, a — Oc.10x, ob. 10x, and 
b–in monolayer culture, oc.10x, ob. 
40x.White arrows pointed out nega-
tive nuclear reaction, green arrows 
pointed out positive nuclear reaction.
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Оптимізація моделі визначення динаміки 
міграції пухлинних клітин in vitro
А. О. Кравченко, В. Р. Косач, АІ, К.А. Шкаріна, 
І. В. Заєць, І. О. Тихонкова, А.І. Хоруженко
Міграційна здатність є важливою ознакою пухлинних 
клітин. Існує кілька підходів до аналізу динаміки мі-
грації ракових клітин in vitro. Однією з найбільш пер-
спективних і близьких до умов in vivo є модель ініці-
ювання міграції клітин  з тривимірного багатоклітин-
ного сфероїда на ростову поверхню. Мета. Оптимізація 
моделі для адекватної кількісної оцінки міграції пух-
линних клітин. Методи. 2- та 3-вимірна культура клі-
тин лінії MCF-7, імунофлюоресцентний аналіз, аналіз 
зображень з використанням комп’ютерної програми 
Фіджі. Результати. Уніфікація розміру сфероїдів до-
зволила уникнути значного розкиду даних. Отримані 
сфероїди повністю розпластувались протягом 3 днів. 
Найвищий показник міграції спостерігався на 2-гу 
добу розпластування сфероїда. Рівень проліферації 
клітин за кожну добу 3-денного експерименту був 
майже однаковим і не перевищував 3 %. Валідність 
моделі була протестована після пригнічення міграцій-
ної активності клітин під впливом рапаміцину (інгібі-
тор сигналізації mTOR). Крім того, запропонована 
модель була успішно застосована для дослідження 
субклітинної локалізації p85S6K1 в мігруючих кліти-
нах лінії MCF-7 за допомогою імунофлюоресцентно-
го аналізу. Висновки. Подвійне фільтрування багато-
клітинних сфероїдів дозволяє уніфікувати їх розміри, 
що в подальшому сприяє адекватній оцінці міграцій-
ного потенціалу клітин. Запропонована модель до-
зволяє вивчати динаміку міграційних процесів пух-
линних клітин і може бути використана для тестуван-
ня протипухлинних препаратів in vitro.
К л юч ов і  с л ов а: Міграція ракових клітин, 2- та 
тривимірна культура клітин, p85S6K1, сфероїди.
Оптимизация модели определения динамики 
миграции опухолевых клеток in vitro
А. А. Кравченко, В. Р. Косач, К. А. Шкарина, 
И. В. Заец, И. А Тихонкова, А. И. Хоруженко
Миграционная способность является важным призна-
ком опухолевых клеток. Существует несколько подхо-
дов к анализу динамики миграции ракових клеток in 
vitro. Одним из наиболее перспективных и близких к 
условиям in vivo является модель инициирования ми-
грации клеток из трехмерного многоклеточного сфе-
роида на ростовую поверхность. Цель. Оптимизация 
модели для адекватной количественной характеристи-
ки миграции опухолевых клеток. Методы. 2- и 3-мер-
ная культура клеток линии MCF-7, иммунофлюорес-
центный анализ, анализ изображений с использовани-
ем компьютерной программы Фиджи. Результаты. 
Унификация размеров сфероидов позволила избежать 
значительного разброса данных. Полученные сферо-
иды полностью распластывались в течение 3 дней. 
Самый високий показатель миграции наблюдался на 
2-е сутки распластования сфероида. Уровень проли-
ферации клеток за каждые сутки 3-дневного экспери-
мента был близьким и не превышал 3 %. Валидность 
модели была протестирована после подавления мигра-
ции под влиянием рапамицина (ингибитор сигнализа-
ции mTOR). Кроме того, предложенная модель была 
успешно применена для исследования субклеточной 
локализации p85S6K1 в мигрирующих клетках линии 
MCF-7 с помощью иммунофлюоресцентного анализа. 
Выводы. Двойная фильтрация генерируемых in vitro 
многоклеточных сфероидов позволила унифицировать 
их размер, что способствует адекватной оценке мигра-
ционного потенцала клеток. Предложенная модель 
позволяет изучать динамику миграционных процессов 
опухолевых клеток и может бать использована для 
тестирования противоопухолевых препаратов in vitro.
К л юч е в ы е  с л ов а: Миграция ракових клеток, 
двух- и трехмерная культура клеток, p85S6K1, сферо-
иды.
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